SciSparc Ltd.
SPRC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001611746
No open-market purchases or sales by SciSparc Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $296.4K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding SciSparc Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 3 | 8 | +5 |
| Shares | 3.28K | 53.8K | +50.5K (+1,539.3%) |
| Value | $12.0K | $296.4K | +$284.4K (+2,369.2%) |
New holders (6)
Institutions that held SciSparc Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 21,235 | $117.0K | 0.00% |
| Jane Street Group, LLC | 16,496 | $91.1K | 0.00% |
| Citadel Advisors LLC | 11,065 | $61.1K | 0.00% |
| JPMorgan Chase & Co | 211 | $1.18K | 0.00% |
| Morgan Stanley | 200 | $1.10K | 0.00% |
| Royal Bank of Canada | 32 | $0 | 0.00% |
Sold out (1)
Institutions that held SciSparc Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Strategic Investment Solutions, Inc. | 133 | $487 |